R Miceli, H Eriksson, GL Russo, S Alfieri… - Acta …, 2024 - pmc.ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICIs) have significantly improved outcomes in
various cancers. ICI treatment is associated with the incidence of immune-related adverse …